fda hiv - Search News

News

FDA approves HIV prevention drug taken

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

CBS News on MSN · 23h

FDA approves HIV prevention drug taken as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Yahoo · 2h

FDA approves world's first twice-a-year shot to prevent HIV

Two clinical trials show the injection is nearly 100% effective at stopping new HIV infections. The vaccine is marketed under the name Yeztugo and can be used by both men and women.

FDA approves the world's only twice-a-year shot to prevent HIV

The U.S. Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. (Scripps News) ...

3hon MSN

FDA approves twice-yearly shot to prevent HIV

ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to approve the world’s only twice-a-year injectable form of PrEP.

11hon MSN

Revolutionary New Drug Offers 99.9% Protection Against HIV

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...

Fierce Pharma1d

FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results